Intelligence Β· Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors β phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β searchable for business development and competitive intelligence.
-
"Nycoplus Magnesium" (120 mg x 3 daily for 2 weeks)
Takeda
Cramps
1 trial -
Cohort A will receive an initial load dose of 8mg/kg and a maintenance dose of 6mg/kg intravenously on the first day of every three weeks for a total of 4 doses
The First People's Hospital of Lianyungang
HER2 Positive Breast Cancer
1 trial -
Dexmedetomidine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Thoracic Paravertebral Blocks
1 trial -
Experimental continuous peripheral nerve blocks
United Therapeutics Europe Ltd
Lower Extremity Surgical Amputation
1 trial -
Inactivated SARS-CoV-2 Vaccine (Vero cell) Lot 1 of the workshop 2
Sinovac Research and Development Co.,
COVID-19
1 trial -
Levosimendan Kalceks 2,5Β mg/ml concentraat voor oplossing voor infusie, Soluvit N poeder voor oplossing voor intraveneuze infusie
Disc Medicine
Failure to wean from invasive ventilation.
1 trial -
VYDURA 75 mg oral lyophilisate, Placebo for Rimegepant 75 mg
Pfizer Australia Pty Ltd
Migraine attacks with or without aura
1 trial -
oral entecavir 0.5mg daily and adefovir 10mg daily for 144 weeks
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Chronic Hepatitis B
1 trial -
Fenugreek Seeds Extract
Chemical Works of Gedeon Richter Plc. (Gedeon Richter Plc.)
Hypogonadism
1 trial -
Screening only
Hospital Authority, Hong Kong
Panic Attacks and Disorders
1 trial -
Study subjects will be vaccinated with 3 (three) vaccine doses. The first vaccine will be administered intramuscularly starting at 6-12 weeks of age followed by two doses at four-week interval
Biotech Pharmaceutical Co.,
Diphtheria
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1β3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources